Microneedle-facilitated Portulaca oleracea L.-derived nanovesicles ameliorate atopic dermatitis by modulating macrophage M1/M2 polarization and inhibiting NF-κB and STING signaling pathways
Acta Pharmaceutica Sinica B · 2025-11 · 15 (11) · 5966-5987
DOI: 10.1016/j.apsb.2025.08.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-11. Verfasst von Meng Long und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Laboratory Animal Service & Experiments, the Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 20…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai University of Traditional Chinese Medicine, Chinese Academy of Sciences.
Abstract (Originalsprache)
Clinical management of atopic dermatitis (AD) is challenged by its susceptibility to recurrence, side effects, and high costs. We found that Portulaca oleracea L.-derived nanovesicles (PDNV) exert anti-inflammatory effects by modulating macrophage M1/M2 polarization. These effects were achieved through pathways including inhibition of nuclear factor-κB (NF-κB) and stimulator of interferon genes (STING) protein expression in diseased tissues, demonstrating their potential to ameliorate AD symptoms. To increase the transdermal permeation of PDNV, dissolvable microneedles composed primarily of hyaluronic acid (HA) were developed as an adjunctive means of delivery. Meanwhile, polysaccharides of Portulaca oleracea L., which were synergistic with PDNV, were used as microneedle constituent materials to enhance the mechanical properties and physical stability of HA. This new means of delivery significantly improves the treatment of AD and also provides new options for the efficient utilization of plant extracellular vesicles and the treatment of AD. In addition, transcriptomic analysis of PDNV showed that the mRNAs of Portulaca oleracea L. are closest to those of ferns, which may shed light on related evolutionary and plant species identification studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Laboratory Animal Service & Experiments, the Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- The Oriental Beauty Valley Group Metron (Shanghai) Technology Co., Ltd., the Oriental Beauty Valley Research Center for Active Plant Materials, Shanghai 201403, China.
Förderung
- Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
- Shanghai University of Traditional Chinese Medicine
- Chinese Academy of Sciences
- Shanghai Advanced Research Institute, Chinese Academy of Sciences
- National Natural Science Foundation of China
- Tongji University
Zitieren
APA
Long, M., Li, J., Zhu, Y., Ruan, H., Li, J., Xu, F., Liu, R., Yang, T., Shi, Y., Feng, N., & Zhang, Y. (2025). Microneedle-facilitated Portulaca oleracea L.-derived nanovesicles ameliorate atopic dermatitis by modulating macrophage M1/M2 polarization and inhibiting NF-κB and STING signaling pathways. Acta Pharmaceutica Sinica B, 15(11), 5966-5987. https://doi.org/10.1016/j.apsb.2025.08.021
Vancouver
Long M, Li J, Zhu Y, Ruan H, Li J, Xu F, et al. Microneedle-facilitated Portulaca oleracea L.-derived nanovesicles ameliorate atopic dermatitis by modulating macrophage M1/M2 polarization and inhibiting NF-κB and STING signaling pathways. Acta Pharmaceutica Sinica B. 2025;15(11):5966-5987. doi:10.1016/j.apsb.2025.08.021
BibTeX
@article{Long2025,
author = {Long, Meng and Li, Jiaqi and Zhu, Yuecheng and Ruan, Hang and Li, Jing and Xu, Fanjun and Liu, Ruipeng and Yang, Tao and Shi, Yanqin and Feng, Nianping and Zhang, Yongtai},
title = {Microneedle-facilitated Portulaca oleracea L.-derived nanovesicles ameliorate atopic dermatitis by modulating macrophage M1/M2 polarization and inhibiting NF-κB and STING signaling pathways},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {15},
number = {11},
pages = {5966--5987},
doi = {10.1016/j.apsb.2025.08.021}
}
EUVIMED